This study was conducted to assess right and left atrial hemostatic functio
n in patients with mitral stenosis (MS) and to investigate the immediate ef
fect of balloon mitral valvuloplasty (BMV) on hemostatic function. BMV was
performed in 28 patients with MS (age 29 +/- 8 years) who had sinus rhythm
and no left atrial (LA) thrombus. Right and left atrial biochemical markers
of platelet activity (platelet factor 4 [PF4] and B thromboglobulin [BTG])
, coagulation (thrombin-antithrombin III complex [TAT]), and fibrinolytic a
ctivity (D-dimer) were measured before and 30 minutes after BMV. Right atri
al levels of these markers were also measured in 20 control subjects. Compa
red with control subjects, patients with MS had higher right atrial levels
of PF4 (30 +/- 15 vs 5 +/- 2 IU/ml), BTG (231 +/- 53 vs 30 +/- 8 IU/ml), TA
T (7 +/- 4 vs 2 +/- 0.3 mu g/L), and D-dimer (380 +/- 145 vs 160 +/- 35 ng/
ml, p <0.0001 in all). TAT levels were higher in the left atrium than in th
e right atrium of patients before BMV (8 +/- 4 vs 7 +/- 4 mu g/L, p <0.0001
). BMV was successful (final mitral valve area greater than or equal to 1.5
cm(2) and greater than or equal to 50% increase of the initial valve area)
in all patients. There was a significant reduction of LA levels of PF4 (35
+/- 8 to 26 +/- 9 IU/ml, p <0.0001), BTG (225 +/- 41 to 196 +/- 28 IU/ml,
p <0.001), and TAT (10 +/- 5 to 7 +/- 1 mu g/L, p <0.05) in the 16 patients
with LA pressure <10 mm Hg after BMV, whereas these markers were not reduc
ed in the 12 patients with left atrial pressure greater than or equal to 10
mm Hg offer BMV. These data indicate that platelet function, coagulation s
tatus, and fibrinolytic activity are increased regionally in the left atriu
m and in the systemic circulation in patients with MS and sinus rhythm in t
he absence of LA thrombus. Successful BMV induces a significant reduction o
f prethrombotic status in patients with low LA pressure after the procedure
. Patients with high LA pressure after BMV maintain a high prethrombotic st
ate and may be considered at an increased risk of thromboembolism after the
procedure. (C)2000 by Excerpta Medica, Inc.